Drexel Morgan & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.96M | Hold |
2,134
| – | – | 0.29% | 36 |
|
|
2025
Q4 | $2.29M | Hold |
2,134
| – | – | 0.36% | 32 |
|
|
2025
Q3 | $1.63M | Hold |
2,134
| – | – | 0.26% | 34 |
|
|
2025
Q2 | $1.66M | Hold |
2,134
| – | – | 0.3% | 33 |
|
|
2025
Q1 | $1.76M | Hold |
2,134
| – | – | 0.37% | 32 |
|
|
2024
Q4 | $1.65M | Hold |
2,134
| – | – | 0.34% | 34 |
|
|
2024
Q3 | $1.89M | Hold |
2,134
| – | – | 0.35% | 33 |
|
|
2024
Q2 | $1.93M | Hold |
2,134
| – | – | 0.41% | 29 |
|
|
2024
Q1 | $1.66M | Hold |
2,134
| – | – | 0.34% | 32 |
|
|
2023
Q4 | $1.24M | Buy |
2,134
+134
| +7% | +$78.2K | 0.29% | 33 |
|
|
2023
Q3 | $1.07M | Hold |
2,000
| – | – | 0.29% | 34 |
|
|
2023
Q2 | $938K | Hold |
2,000
| – | – | 0.24% | 37 |
|
|
2023
Q1 | $687K | Hold |
2,000
| – | – | 0.17% | 37 |
|
|
2022
Q4 | $732K | Hold |
2,000
| – | – | 0.15% | 37 |
|
|
2022
Q3 | $647K | Hold |
2,000
| – | – | 0.16% | 37 |
|
|
2022
Q2 | $648K | Hold |
2,000
| – | – | 0.18% | 36 |
|
|
2022
Q1 | $573K | Hold |
2,000
| – | – | 0.17% | 35 |
|
|
2021
Q4 | $552K | Hold |
2,000
| – | – | 0.16% | 37 |
|
|
2021
Q3 | $462K | Sell |
2,000
-500
| -20% | -$123K | 0.15% | 36 |
|
|
2021
Q2 | $574K | Buy |
2,500
+500
| +25% | +$100K | 0.17% | 51 |
|
|
2021
Q1 | $374K | Sell |
2,000
-6
| -0.3% | -$1.17K | 0.09% | 76 |
|
|
2020
Q4 | $339K | Hold |
2,006
| – | – | 0.09% | 76 |
|
|
2020
Q3 | $297K | Hold |
2,006
| – | – | 0.1% | 79 |
|
|
2020
Q2 | $329K | Hold |
2,006
| – | – | 0.12% | 77 |
|
|
2020
Q1 | $278K | Hold |
2,006
| – | – | 0.11% | 75 |
|
|
2019
Q4 | $264K | Buy |
2,006
+6
| +0.3% | +$695 | 0.2% | 76 |
|
|
2019
Q3 | $224K | Hold |
2,000
| – | – | 0.17% | 81 |
|
|
2019
Q2 | $222K | Hold |
2,000
| – | – | 0.17% | 85 |
|
|
2019
Q1 | $260K | Hold |
2,000
| – | – | 0.23% | 78 |
|
|
2018
Q4 | $231K | Hold |
2,000
| – | – | 0.23% | 82 |
|
|
2018
Q3 | $215K | Buy |
+2,000
| New | +$200K | 0.19% | 88 |
|
|
2018
Q1 | – | Sell |
-2,645
| Closed | -$223K | – | 88 |
|
|
2017
Q4 | $223K | Hold |
2,645
| – | – | 0.22% | 86 |
|
|
2017
Q3 | $226K | Hold |
2,645
| – | – | 0.23% | 84 |
|
|
2017
Q2 | $218K | Buy |
+2,645
| New | +$216K | 0.22% | 82 |
|
Other funds holding LLY
VCM
VPM
Drexel Morgan & Co's LLY Position: Q1 2026 in Review
Drexel Morgan & Co held its Eli Lilly (LLY) position steady in Q1 2026 at 2,134 shares worth $1.96M. The position accounts for 0.29% of the portfolio, ranked #36.
Drexel Morgan & Co first reported a position in LLY in Q2 2017 and has held it in 34 quarters since. The position peaked at $2.29M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Drexel Morgan & Co held 2,134 shares of Eli Lilly worth $1.96M as of Q1 2026.
- Drexel Morgan & Co left its Eli Lilly share count unchanged in Q1 2026.
- Eli Lilly made up 0.29% of Drexel Morgan & Co's portfolio in Q1 2026, its #36 holding.
- Drexel Morgan & Co first reported a position in Eli Lilly in Q2 2017 and has held it in 34 quarters since.
- Drexel Morgan & Co's Eli Lilly position peaked at $2.29M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Drexel Morgan & Co's 13F filing for Q1 2026, filed 11 May 2026.